2026
Oct (2)
Feb (40)
Jan (46)
2025
Apr (1)
Mar (4)
Feb (3)
Jan (6)
2024
Dec (3)
Nov (3)
Oct (2)
Sep (3)
Aug (2)
Jul (6)
Jun (7)
May (3)
Apr (6)
Mar (4)
Feb (2)
Jan (4)
2023
Dec (1)
Nov (6)
Oct (5)
Sep (2)
Aug (7)
Jul (8)
Jun (6)
May (4)
2019
Mar (3)
Feb (2)
Jan (1)
2018
Nov (2)
Oct (4)
Sep (2)
Aug (4)
Jul (2)
Jun (3)
Apr (5)
Mar (2)
Feb (1)
2017
Dec (4)
Nov (1)
Oct (1)
Sep (2)
Aug (3)
Jul (4)
Jun (3)
May (2)
Mar (4)
Feb (1)
Jan (3)
2016
Dec (1)
Nov (3)
Oct (2)
Sep (2)
Aug (3)
Jul (2)
Jun (2)
May (7)
Apr (2)
Mar (5)
Feb (1)
Jan (3)
2015
Nov (5)
Oct (4)
Sep (2)
Aug (2)
Jul (2)
Jun (3)
May (6)
Apr (2)
Mar (4)
Feb (3)
Jan (2)
2014
Dec (4)
Nov (1)
2004
Aug (1)
Jul (6)
Jun (3)
May (13)
Apr (4)
Mar (3)
Feb (3)
Jan (11)
2003
Dec (13)
Nov (37)
Oct (7)
Sep (8)
Aug (3)
Jul (17)
Jun (3)
May (5)
Apr (8)
Mar (5)
Feb (3)
Jan (5)
2002
Dec (4)
Nov (2)
Oct (3)
Sep (8)
Aug (7)
Jul (9)
Jun (14)
May (8)
Apr (7)
Mar (10)
Feb (1)
October 2026
October 8, 2026
NAD-boosting treatment fails to show benefits for Parkinson's in major trial
A clinical trial involving 410 participants with early Parkinson's disease found that nicotinamide riboside (NR) showed no clinical benefits. The study, published in JAMA, raises…
October 2, 2026
Cancer Stem Cells' Energy Dependence Offers New Treatment Possibilities
Researchers discovered that high-risk MDS stem cells have a significant reliance on NAD, an energy molecule, which could be targeted for cancer treatment. This finding…